Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

52.34 -0.54 (-1.02%)

Streaming Delayed Price Updated: 10:21 AM EDT, Aug 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

45 46 Next >

(GSK) - Analyzing GSK's Short Interest ↗

July 07, 2023

Via Benzinga

From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs ↗

July 07, 2023

Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as...

Via Benzinga

Analyst Creates Bullish Pitch For WAVE Life Sciences, Says It Is 'Leader To Clinic In RNA Editing' ↗

July 05, 2023

Raymond James has initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a price target of $9 and

Via Benzinga

Teva's Strategic Evaluation: Israeli Pharma Company Mulls Divesting $2B Active Ingredients Unit ↗

July 05, 2023

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is reportedly considering potential strategic options for its active pharmaceutical ingredients (API) unit, which could include a potential sale.

Via Benzinga

Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults ↗

July 05, 2023

Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in

Via Benzinga

Better Artificial Intelligence Stock: GSK or Eli Lilly? ↗

June 28, 2023

Which of these AI-powered drugmakers is the better buy right now?

Via The Motley Fool

Is GSK a Strong Buy Right Now? ↗

June 26, 2023

The drugmaker ought to appeal to value and income investors.

Via The Motley Fool

2 Stocks Defying Friday's Market Downturn ↗

June 23, 2023

Stock markets opened lower as Wall Street took a pause from the bull run.

Via The Motley Fool

Haleon Contemplates Sale of Non-Core Businesses, Including Nicotinell Brand: A Strategy Shift Towards Core Products ↗

July 05, 2023

Haleon Plc (NYSE: HLN), a consumer health company, is reportedly considering divesting some smoking cessation products as part of a strategy to sell non-core businesses.

Via Benzinga

First US Trial Over Zantac's Alleged Cancer-Causing Properties Set For November In California ↗

July 03, 2023

The initial U.S. court trial concerning the antacid medication Zantac is slated to commence on November 13 in a state court in California, as stated by a lawyer representing the plaintiffs.

Via Benzinga

Drugmaker GSK: Becoming a Healthier Value Stock

June 27, 2023

Up more than 25% in the last nine months, U.K. pharmaceutical company GSK PLC is slowly regaining favor with investors after the GSK lawsuit.

Via MarketBeat

Topics Lawsuit

Baidu Says Ernie Bot Beats ChatGPT, Meta's WhatsApp Business Soars Past 200M Users, Walgreens Earnings Disappointment: Today's Top Stories ↗

June 27, 2023

CNBC ChatGPT Vs. Baidu's Ernie Bot - Chinese Tech Giant Says Ernie Beat ChatGPT

Via Benzinga

Second Most Prevalent Bacterial Sexually Transmitted Infection: GSK's Gonorrhea Vaccine Secures FDA Track ↗

June 27, 2023

The FDA has granted Fast Track designation to GSK plc's (NYSE:

Via Benzinga

Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics ↗

June 26, 2023

As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other...

Via Benzinga

Why Shares of CureVac Jumped This Week ↗

June 23, 2023

The company, which focuses on mRNA therapies, began a phase 1 trial for its cancer vaccine candidate.

Via The Motley Fool

Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 23, 2023

Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'.

Via Benzinga

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms ↗

June 23, 2023

GSK settled with James Goetz for an undisclosed amount of money. But thousands of cases remain.

Via Investor's Business Daily

Crypto Analyst Says Bitcoin Can Break $32K Level, Nikola Moves Forward With Test Road Trips Despite Weak Demand & Internal Conflict, Retailers' Subscriptions Under FTC Scrutiny: Today's Top Stories ↗

June 23, 2023

Benzinga

Via Benzinga

GSK Confidentially Settles First Zantac-Associated Cancer Lawsuit Due For US Trial Next Month ↗

June 23, 2023

GSK plc (NYSE: GSK) has reached a confidential settlement with James Goet

Via Benzinga

Trupanion, IonQ, 3M And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

June 23, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Intel Voices Plans To Restructure Manufacturing Business, Bumble's BFF App, Spirit AeroSystems To Stop Work At Kansas Plant Amid Workers Strike: Today's Top Stories ↗

June 22, 2023

Reuters

Via Benzinga

RSV Vaccines from Pfizer and GSK Gain CDC Advisory Committee's Favor for Older Adults ↗

June 22, 2023

The US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices voted in favor of recommending the use of RSV vaccines from Pfizer Inc (NYSE: PFE) and GSK...

Via Benzinga

7 Healthcare Stocks to Make You the Millionaire Next Door ↗

June 21, 2023

For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy.

Via InvestorPlace

US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making

June 21, 2023

From GSK plc

Via Business Wire

Pfizer's Elderly Vaccine Efficacy Drops Slightly After 18 Months, New Clinical Trials Reveal - CDC Advisory Panel Set To Vote Today On Recommended Use Of RSV Shots ↗

June 21, 2023

Pfizer Inc's (NYSE: PFE) vaccine for elderly 60 and above was slightly less effective after 18 months, according to the company's clinical trial

Via Benzinga

GSK's Recently Approved Vaccine Offers Long-Term Protection Against RSV in Older Adults, New Data Reveals ↗

June 21, 2023

GSK plc (NYSE: GSK) announced

Via Benzinga

GSK shares positive data for AREXVY, its respiratory syncytial virus (RSV) older adult vaccine, indicating protection over two RSV seasons

June 21, 2023

From GSK plc

Via Business Wire

GSK and Lifetime® Release Short Film Featuring Soleil Moon Frye and Melissa Joan Hart Urging Parents to “Ask2BSure” about Meningitis B

June 20, 2023

From GSK plc

Via Business Wire

Sanofi Stock Is Trading Higher Today - Here's Why ↗

June 20, 2023

Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to...

Via Benzinga

3 Undervalued Consumer Stocks to Buy in June ↗

June 20, 2023

These undervalued consumer stocks to buy could attract investor attention as possible hedges against inflation and a recession.

Via InvestorPlace

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

45 46 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

Starting at /week.